RA Medical Systems (RMED) Coverage Initiated by Analysts at Maxim Group

Maxim Group started coverage on shares of RA Medical Systems (NYSE:RMED) in a research note published on Friday, Marketbeat.com reports. The firm issued a buy rating and a $23.00 price objective on the stock.

RMED has been the subject of a number of other reports. Piper Jaffray Companies started coverage on shares of RA Medical Systems in a research report on Monday, October 22nd. They set an overweight rating and a $23.00 price objective for the company. Cantor Fitzgerald started coverage on shares of RA Medical Systems in a research report on Monday, October 22nd. They set an overweight rating and a $21.00 price objective for the company. Finally, SunTrust Banks started coverage on shares of RA Medical Systems in a research report on Monday, October 22nd. They set a buy rating and a $16.00 price objective for the company.

RMED stock traded up $0.30 during trading on Friday, reaching $10.85. 63,405 shares of the company were exchanged, compared to its average volume of 113,189. RA Medical Systems has a twelve month low of $10.35 and a twelve month high of $22.00.

A hedge fund recently bought a new stake in RA Medical Systems stock. Rockefeller Capital Management L.P. purchased a new stake in RA Medical Systems Inc (NYSE:RMED) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,592 shares of the company’s stock, valued at approximately $120,000. Rockefeller Capital Management L.P. owned 0.05% of RA Medical Systems as of its most recent filing with the Securities and Exchange Commission.

About RA Medical Systems

Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.

Read More: Market Capitalization and Individual Investors

Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply